Abiraterone

Abiraterone acetate tablets are indicated in combination with prednisone for the treatment of patients with Metastatic castration-resistant prostate cancer (CRPC) Metastatic high-risk castration-sensitive prostate cancer (CSPC) Abiraterone…

Prescribing label

Selected manufacturer label information, organised into consistent sections by Sofidex. This source is written for healthcare professionals; ask your pharmacist to explain instructions that are unclear. Read the full label at DailyMed ↗

Drug facts

Used for: Abiraterone acetate tablets are indicated in combination with prednisone for the treatment of patients with Metastatic castration-resistant prostate cancer (CRPC) Metastatic high-risk castration-sensitive prostate cancer (CSPC) Abiraterone…

What it is used for

Abiraterone acetate tablets are indicated in combination with prednisone for the treatment of patients with

Metastatic castration-resistant prostate cancer (CRPC)

Side effects, and when to stop

The following are discussed in more detail in other sections of the labeling:

Hypokalemia, Fluid Retention, and Cardiovascular Adverse Reactions due to Mineralocorticoid Excess.
Adrenocortical Insufficiency.
Hepatotoxicity.
Increased Fractures and Mortality in Combination with Radium Ra 223 Dichloride.

Who should not take it

None.

Cite this page

NLM: sofidex [Internet]. Daloreum; c2026. Abiraterone; [reviewed 2026 Aug 2; cited 2026 Nov 10]. Available from: https://sofidex.com/patients/medicines/abiraterone
APA 7th: sofidex. (2026, August 2). Abiraterone. Daloreum. Retrieved November 10, 2026, from https://sofidex.com/patients/medicines/abiraterone
AMA 11th: Abiraterone. sofidex. Reviewed August 2, 2026. Accessed November 10, 2026. https://sofidex.com/patients/medicines/abiraterone

The cited date is today’s, because a citation records when you read the page. The reviewed date is when a clinician last checked it.